• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白激酶C η与肾细胞癌(RCC)的进展相关。

Protein kinase C eta is associated with progression of renal cell carcinoma (RCC).

作者信息

Brenner Walburgis, Färber Gloria, Herget Thomas, Wiesner Christoph, Hengstler Jan G, Thüroff Joachim W

机构信息

Department of Urology, University of Mainz, Langenbeckstr. 1, 55131 Mainz, Germany.

出版信息

Anticancer Res. 2003 Sep-Oct;23(5A):4001-6.

PMID:14666709
Abstract

BACKGROUND

The expression of all eleven PKC-isoforms in clear cell RCCs (ccRCC) and in the corresponding normal renal tissue was quantified. A possible association of PKC-isoforms with histopathological parameters was examined.

MATERIALS AND METHODS

Proteins were isolated from tumor and normal tissue of 43 patients with ccRCC. Expression of PKC-isoforms were quantified by Western blot analysis.

RESULTS

In both, ccRCCs and the corresponding normal renal tissue, all PKC-isoforms apart from PKC gamma and theta were detectable. Striking associations between PKC-isoforms and histopathological parameters were observed: (i) a 3-fold increase in PKC eta of grade 3 and 4 versus grade 1 and 2 tumors (p = 0.025), (ii) a decrease of PKC alpha in tumor versus normal tissue of 18% (p = 0.020) and (iii) a 20% increase of PKC zeta in grade 3 and 4 versus grade 1 and 2 tumors (p = 0.092).

CONCLUSION

The major result is a clear correlation of PKC eta expression with tumor progression. This observation-is in agreement with the known oncogenic properties of PKC eta. Similarly, oncogenic PKC zeta also increased with tumor progression. PKC alpha, with known tumor-suppressor properties, was decreased in ccRCC versus normal tissue. These findings may become important for both classification and treatment of ccRCC.

摘要

背景

对透明细胞肾细胞癌(ccRCC)及相应正常肾组织中所有11种蛋白激酶C(PKC)亚型的表达进行了定量分析,并研究了PKC亚型与组织病理学参数之间的可能关联。

材料与方法

从43例ccRCC患者的肿瘤组织和正常组织中分离蛋白质,通过蛋白质印迹分析对PKC亚型的表达进行定量。

结果

在ccRCC及其相应的正常肾组织中,除PKCγ和θ外,所有PKC亚型均可检测到。观察到PKC亚型与组织病理学参数之间存在显著关联:(i)3级和4级肿瘤的PKCη表达较1级和2级肿瘤增加3倍(p = 0.025);(ii)肿瘤组织中的PKCα较正常组织降低18%(p = 0.020);(iii)3级和4级肿瘤的PKCζ较1级和2级肿瘤增加20%(p = 0.092)。

结论

主要结果是PKCη表达与肿瘤进展明显相关。这一观察结果与PKCη已知的致癌特性相符。同样,致癌性PKCζ也随肿瘤进展而增加。具有已知肿瘤抑制特性的PKCα在ccRCC中较正常组织减少。这些发现可能对ccRCC的分类和治疗都具有重要意义。

相似文献

1
Protein kinase C eta is associated with progression of renal cell carcinoma (RCC).蛋白激酶C η与肾细胞癌(RCC)的进展相关。
Anticancer Res. 2003 Sep-Oct;23(5A):4001-6.
2
Protein kinase C in human renal cell carcinomas: role in invasion and differential isoenzyme expression.蛋白激酶C在人肾细胞癌中的作用:在侵袭及不同同工酶表达中的作用
Br J Cancer. 2000 Mar;82(5):1063-9. doi: 10.1054/bjoc.1999.1043.
3
Expression of protein kinase C isoenzymes in benign hyperplasia and carcinoma of prostate.蛋白激酶C同工酶在前列腺良性增生和癌中的表达
Oncol Rep. 2004 Feb;11(2):321-6.
4
Migration of renal carcinoma cells is dependent on protein kinase Cdelta via beta1 integrin and focal adhesion kinase.肾癌细胞的迁移通过β1整合素和粘着斑激酶依赖于蛋白激酶Cδ。
Int J Oncol. 2008 May;32(5):1125-31.
5
Cyclooxygenase-2 expression and relationship to tumour progression in human renal cell carcinoma.环氧化酶-2在人肾细胞癌中的表达及其与肿瘤进展的关系。
Histopathology. 2004 Apr;44(4):353-9. doi: 10.1111/j.1365-2559.2004.01853.x.
6
Characterization of patterns of expression of protein kinase C-alpha, -delta, -eta, -gamma and -zeta and their correlations to p53, galectin-3, the retinoic acid receptor-beta and the macrophage migration inhibitory factor (MIF) in human cholesteatomas.人胆脂瘤中蛋白激酶C-α、-δ、-η、-γ和-ζ的表达模式及其与p53、半乳糖凝集素-3、视黄酸受体-β和巨噬细胞移动抑制因子(MIF)的相关性特征
Hear Res. 2006 Apr;214(1-2):7-16. doi: 10.1016/j.heares.2006.01.013. Epub 2006 Mar 2.
7
Patterns of protein kinase C isoenzyme expression in transitional cell carcinoma of bladder. Relation to degree of malignancy.膀胱移行细胞癌中蛋白激酶C同工酶的表达模式。与恶性程度的关系。
Am J Clin Pathol. 2001 Sep;116(3):377-85. doi: 10.1309/1VKK-HWH7-YVJN-7UF7.
8
Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.I型和II型乳头状肾细胞癌(RCC)与透明细胞肾细胞癌的比较。
BJU Int. 2008 Nov;102(10):1381-4. doi: 10.1111/j.1464-410X.2008.07999.x. Epub 2008 Sep 8.
9
Differential expression of caveolin-1 in renal neoplasms.小窝蛋白-1在肾肿瘤中的差异表达。
Cancer. 2007 Aug 15;110(4):776-82. doi: 10.1002/cncr.22838.
10
The expression of hypoxia-inducible factor 1alpha is a favorable independent prognostic factor in renal cell carcinoma.缺氧诱导因子1α的表达是肾细胞癌中一个良好的独立预后因素。
Clin Cancer Res. 2005 Feb 1;11(3):1129-35.

引用本文的文献

1
An Update on Protein Kinases as Therapeutic Targets-Part I: Protein Kinase C Activation and Its Role in Cancer and Cardiovascular Diseases.蛋白激酶作为治疗靶点的最新研究进展——第一部分:蛋白激酶 C 的激活及其在癌症和心血管疾病中的作用。
Int J Mol Sci. 2023 Dec 18;24(24):17600. doi: 10.3390/ijms242417600.
2
Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for Cancer.蛋白激酶C(PKC)同工酶作为癌症的诊断和预后生物标志物及治疗靶点
Cancers (Basel). 2022 Nov 3;14(21):5425. doi: 10.3390/cancers14215425.
3
Differentially expressed autophagy-related genes are potential prognostic and diagnostic biomarkers in clear-cell renal cell carcinoma.
差异表达的自噬相关基因是透明细胞肾细胞癌潜在的预后和诊断生物标志物。
Aging (Albany NY). 2019 Oct 17;11(20):9025-9042. doi: 10.18632/aging.102368.
4
The Enigmatic Protein Kinase C-eta.神秘的蛋白激酶C-η
Cancers (Basel). 2019 Feb 13;11(2):214. doi: 10.3390/cancers11020214.
5
Integrin α5 triggers the metastatic potential in renal cell carcinoma.整合素α5触发肾细胞癌的转移潜能。
Oncotarget. 2017 Nov 18;8(64):107530-107542. doi: 10.18632/oncotarget.22501. eCollection 2017 Dec 8.
6
miR-24-3p Suppresses Malignant Behavior of Lacrimal Adenoid Cystic Carcinoma by Targeting PRKCH to Regulate p53/p21 Pathway.miR-24-3p通过靶向PRKCH调节p53/p21通路抑制泪腺腺样囊性癌的恶性行为。
PLoS One. 2016 Jun 28;11(6):e0158433. doi: 10.1371/journal.pone.0158433. eCollection 2016.
7
Protein kinase C and cancer: what we know and what we do not.蛋白激酶C与癌症:我们所知道的和未知的
Oncogene. 2014 Nov 6;33(45):5225-37. doi: 10.1038/onc.2013.524. Epub 2013 Dec 16.
8
Upregulation of PKCη by PKCε and PDK1 involves two distinct mechanisms and promotes breast cancer cell survival.蛋白激酶Cε(PKCε)和3-磷酸肌醇依赖性蛋白激酶-1(PDK1)对蛋白激酶Cη(PKCη)的上调涉及两种不同机制,并促进乳腺癌细胞存活。
Biochim Biophys Acta. 2013 Aug;1830(8):4040-5. doi: 10.1016/j.bbagen.2013.03.028. Epub 2013 Apr 4.
9
The protein kinase C agonist PEP005 (ingenol 3-angelate) in the treatment of human cancer: a balance between efficacy and toxicity.蛋白激酶 C 激动剂 PEP005(ingenol 3-angelate)治疗人类癌症:疗效与毒性之间的平衡。
Toxins (Basel). 2010 Jan;2(1):174-94. doi: 10.3390/toxins2010174. Epub 2010 Jan 22.
10
Adhesion of renal carcinoma cells to endothelial cells depends on PKCmu.肾癌细胞与内皮细胞的黏附依赖于 PKCmu。
BMC Cancer. 2010 May 6;10:183. doi: 10.1186/1471-2407-10-183.